Question: Which nodal involvement category is supported by the examined sections?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. Isolated tumor cells or micrometastasis only
D. No metastatic tumor identified


Question: Which overall regional nodal tumor-burden category is supported by the submitted material?

Choices:
A. Cannot be assessed from the submitted specimen
B. No metastatic tumor identified
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Negative with a clear margin
D. Close but negative


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Negative with a clear margin
D. Positive for invasive tumor


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Close but negative
D. Positive for invasive tumor


Question: How should regional nodal tumor burden be categorized?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only

Cannot be assessed from the submitted specimen


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis

Cannot be assessed from the submitted specimen


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis

Cannot be assessed from the submitted specimen


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. Isolated tumor cells or micrometastasis only
B. No metastatic tumor identified
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis

Isolated tumor cells or micrometastasis only


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. Isolated tumor cells or micrometastasis only
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. No metastatic tumor identified


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Positive for invasive tumor

Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative

Cannot be assessed from the submitted specimen


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: Which level of local invasion is supported by the submitted sections of this urinary bladder tumor?

Choices:
A. Limited to lamina propria or more superficial tissue
B. Directly invades an adjacent organ or the pelvic or abdominal wall
C. Invades perivesical soft tissue
D. Invades muscularis propria


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Close but negative
D. Positive for invasive tumor


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Negative with a clear margin


Question: How should local extension of this colorectal tumor be categorized morphologically?

Choices:
A. Invades the muscularis propria
B. Limited to the submucosa
C. Reaches the serosal surface or directly invades an adjacent organ
D. Extends through muscularis propria into pericolorectal tissue


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Isolated tumor cells or micrometastasis only
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Positive for invasive tumor


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative

Cannot be assessed from the submitted specimen


Question: Which anatomic level of invasion is reached by this renal tumor?

Choices:
A. Invades perinephric or renal sinus soft tissue
B. Extends beyond Gerota fascia or directly invades an adjacent organ
C. Confined to the kidney
D. Invades a major renal vein branch or the vena cava

Invades a major renal vein branch or the vena cava


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: What is the greatest anatomic extent of invasion by this endometrial tumor?

Choices:
A. Myometrial invasion involving at least half of its thickness
B. Cervical stromal, serosal, adnexal, or adjacent-organ extension
C. No myometrial invasion
D. Myometrial invasion involving less than half of its thickness

Myometrial invasion involving less than half of its thickness


Question: Which description best matches the greatest anatomic extent of invasion by this endometrial tumor?

Choices:
A. Myometrial invasion involving at least half of its thickness
B. Cervical stromal, serosal, adnexal, or adjacent-organ extension
C. No myometrial invasion
D. Myometrial invasion involving less than half of its thickness

Cervical stromal, serosal, adnexal, or adjacent-organ extension


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only

Cannot be assessed from the submitted specimen


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Positive for invasive tumor


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. Cannot be assessed from the submitted specimen
B. Isolated tumor cells or micrometastasis only
C. At least one macrometastasis
D. No metastatic tumor identified

Cannot be assessed from the submitted specimen


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: How should regional nodal tumor burden be categorized?

Choices:
A. Isolated tumor cells or micrometastasis only
B. No metastatic tumor identified
C. At least one macrometastasis
D. Cannot be assessed from the submitted specimen


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Negative with a clear margin
D. Close but negative


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. Isolated tumor cells or micrometastasis only
B. No metastatic tumor identified
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Negative with a clear margin


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. Isolated tumor cells or micrometastasis only
D. No metastatic tumor identified


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. At least one macrometastasis
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. No metastatic tumor identified


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: What local anatomic extent is supported for this renal tumor?

Choices:
A. Extends beyond Gerota fascia or directly invades an adjacent organ
B. Invades a major renal vein branch or the vena cava
C. Confined to the kidney
D. Invades perinephric or renal sinus soft tissue


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Close but negative
D. Positive for invasive tumor


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. Isolated tumor cells or micrometastasis only
B. Cannot be assessed from the submitted specimen
C. No metastatic tumor identified
D. At least one macrometastasis


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: Which local-invasion category should be recorded for this colorectal tumor?

Choices:
A. Limited to the submucosa
B. Extends through muscularis propria into pericolorectal tissue
C. Invades the muscularis propria
D. Reaches the serosal surface or directly invades an adjacent organ


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. Cannot be assessed from the submitted specimen
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. At least one macrometastasis


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Positive for invasive tumor


Question: How should regional nodal tumor burden be categorized?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Isolated tumor cells or micrometastasis only
D. Cannot be assessed from the submitted specimen


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Negative with a clear margin
D. Close but negative


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only

Cannot be assessed from the submitted specimen


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor

Cannot be assessed from the submitted specimen


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only

Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: Which level of local invasion is supported by the submitted sections of this urinary bladder tumor?

Choices:
A. Directly invades an adjacent organ or the pelvic or abdominal wall
B. Limited to lamina propria or more superficial tissue
C. Invades perivesical soft tissue
D. Invades muscularis propria


Question: What is the deepest local extension of this renal tumor?

Choices:
A. Invades a major renal vein branch or the vena cava
B. Invades perinephric or renal sinus soft tissue
C. Confined to the kidney
D. Extends beyond Gerota fascia or directly invades an adjacent organ

Invades perinephric or renal sinus soft tissue


Question: What local anatomic extent is supported for this urinary bladder tumor?

Choices:
A. Invades perivesical soft tissue
B. Directly invades an adjacent organ or the pelvic or abdominal wall
C. Limited to lamina propria or more superficial tissue
D. Invades muscularis propria


Question: How should local extension of this colorectal tumor be categorized morphologically?

Choices:
A. Extends through muscularis propria into pericolorectal tissue
B. Limited to the submucosa
C. Invades the muscularis propria
D. Reaches the serosal surface or directly invades an adjacent organ

Extends through muscularis propria into pericolorectal tissue


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: Which overall regional nodal tumor-burden category is supported by the submitted material?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: What level of nodal metastatic burden is supported by the submitted H&E material?

Choices:
A. Cannot be assessed from the submitted specimen
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. At least one macrometastasis


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. At least one macrometastasis
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. No metastatic tumor identified


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. Isolated tumor cells or micrometastasis only
B. Cannot be assessed from the submitted specimen
C. No metastatic tumor identified
D. At least one macrometastasis


Question: Which overall regional nodal tumor-burden category is supported by the submitted material?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: What is the greatest anatomic extent of invasion supported for this endometrial tumor?

Choices:
A. Cervical stromal, serosal, adnexal, or adjacent-organ extension
B. Myometrial invasion involving less than half of its thickness
C. No myometrial invasion
D. Myometrial invasion involving at least half of its thickness

Myometrial invasion involving less than half of its thickness


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. Cannot be assessed from the submitted specimen
B. No metastatic tumor identified
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. At least one macrometastasis
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Negative with a clear margin
D. Positive for invasive tumor


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Negative with a clear margin


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified

Cannot be assessed from the submitted specimen


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative

Cannot be assessed from the submitted specimen


Question: How should regional nodal tumor burden be categorized?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only

Isolated tumor cells or micrometastasis only


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis

Cannot be assessed from the submitted specimen


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis

Cannot be assessed from the submitted specimen


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: What is the greatest nodal tumor burden, if any, identified in the submitted material?

Choices:
A. Isolated tumor cells or micrometastasis only
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. No metastatic tumor identified


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. At least one macrometastasis
B. Cannot be assessed from the submitted specimen
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Negative with a clear margin
D. Positive for invasive tumor


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: How should regional nodal tumor burden be categorized?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. Isolated tumor cells or micrometastasis only
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. No metastatic tumor identified


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. Cannot be assessed from the submitted specimen
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis

Cannot be assessed from the submitted specimen


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. Cannot be assessed from the submitted specimen


Question: How should regional nodal tumor burden be categorized?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. At least one macrometastasis
B. Cannot be assessed from the submitted specimen
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Negative with a clear margin


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. At least one macrometastasis
D. Cannot be assessed from the submitted specimen


Question: Which nodal involvement category is supported by the examined sections?

Choices:
A. Isolated tumor cells or micrometastasis only
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. No metastatic tumor identified


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Negative with a clear margin
D. Positive for invasive tumor


Question: How should regional nodal tumor burden be categorized?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Positive for invasive tumor


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. Cannot be assessed from the submitted specimen
B. Isolated tumor cells or micrometastasis only
C. At least one macrometastasis
D. No metastatic tumor identified


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What is the greatest nodal tumor burden, if any, identified in the submitted material?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: What local anatomic extent is supported for this renal tumor?

Choices:
A. Confined to the kidney
B. Invades perinephric or renal sinus soft tissue
C. Extends beyond Gerota fascia or directly invades an adjacent organ
D. Invades a major renal vein branch or the vena cava

Invades perinephric or renal sinus soft tissue


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: Which description best matches the greatest anatomic extent of invasion by this urinary bladder tumor?

Choices:
A. Invades perivesical soft tissue
B. Limited to lamina propria or more superficial tissue
C. Invades muscularis propria
D. Directly invades an adjacent organ or the pelvic or abdominal wall


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Negative with a clear margin
D. Positive for invasive tumor


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: What level of nodal metastatic burden is supported by the submitted H&E material?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. At least one macrometastasis
D. Cannot be assessed from the submitted specimen


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: How should regional nodal tumor burden be categorized?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only

Cannot be assessed from the submitted specimen


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: How should regional nodal tumor burden be categorized?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: What is the greatest nodal tumor burden, if any, identified in the submitted material?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Negative with a clear margin
D. Close but negative


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: Which anatomic level of invasion is reached by this renal tumor?

Choices:
A. Confined to the kidney
B. Invades a major renal vein branch or the vena cava
C. Extends beyond Gerota fascia or directly invades an adjacent organ
D. Invades perinephric or renal sinus soft tissue

Invades perinephric or renal sinus soft tissue


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Negative with a clear margin


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. Isolated tumor cells or micrometastasis only
B. No metastatic tumor identified
C. At least one macrometastasis
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Positive for invasive tumor


Question: What is the greatest nodal tumor burden, if any, identified in the submitted material?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Negative with a clear margin
D. Close but negative


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. Cannot be assessed from the submitted specimen
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. Cannot be assessed from the submitted specimen


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Positive for invasive tumor


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. Cannot be assessed from the submitted specimen


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only


Question: How should local extension of this renal tumor be categorized morphologically?

Choices:
A. Extends beyond Gerota fascia or directly invades an adjacent organ
B. Invades a major renal vein branch or the vena cava
C. Confined to the kidney
D. Invades perinephric or renal sinus soft tissue

Invades perinephric or renal sinus soft tissue


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified


Question: What level of nodal metastatic burden is supported by the submitted H&E material?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. Cannot be assessed from the submitted specimen


Question: What is the greatest nodal tumor burden, if any, identified in the submitted material?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. Isolated tumor cells or micrometastasis only
D. No metastatic tumor identified

Cannot be assessed from the submitted specimen


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Negative with a clear margin


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor

Cannot be assessed from the submitted specimen


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified

Cannot be assessed from the submitted specimen


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: What is the greatest anatomic extent of invasion by this renal tumor?

Choices:
A. Extends beyond Gerota fascia or directly invades an adjacent organ
B. Invades a major renal vein branch or the vena cava
C. Confined to the kidney
D. Invades perinephric or renal sinus soft tissue

Invades perinephric or renal sinus soft tissue


Question: How should local extension of this renal tumor be categorized morphologically?

Choices:
A. Invades a major renal vein branch or the vena cava
B. Confined to the kidney
C. Extends beyond Gerota fascia or directly invades an adjacent organ
D. Invades perinephric or renal sinus soft tissue

Invades perinephric or renal sinus soft tissue


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. Isolated tumor cells or micrometastasis only
B. No metastatic tumor identified
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: Which anatomic level of invasion is reached by this urinary bladder tumor?

Choices:
A. Limited to lamina propria or more superficial tissue
B. Invades perivesical soft tissue
C. Invades muscularis propria
D. Directly invades an adjacent organ or the pelvic or abdominal wall


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Positive for invasive tumor

Cannot be assessed from the submitted specimen


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: Which anatomic level of invasion is reached by this endometrial tumor?

Choices:
A. Cervical stromal, serosal, adnexal, or adjacent-organ extension
B. Myometrial invasion involving at least half of its thickness
C. Myometrial invasion involving less than half of its thickness
D. No myometrial invasion


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Close but negative
D. Positive for invasive tumor


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: What local anatomic extent is supported for this endometrial tumor?

Choices:
A. Myometrial invasion involving at least half of its thickness
B. Myometrial invasion involving less than half of its thickness
C. No myometrial invasion
D. Cervical stromal, serosal, adnexal, or adjacent-organ extension

Myometrial invasion involving at least half of its thickness


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Close but negative
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. Cannot be assessed from the submitted specimen
B. No metastatic tumor identified
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. Isolated tumor cells or micrometastasis only
B. No metastatic tumor identified
C. At least one macrometastasis
D. Cannot be assessed from the submitted specimen


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Negative with a clear margin
D. Close but negative


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Positive for invasive tumor
D. Close but negative


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Negative with a clear margin


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Close but negative
D. Positive for invasive tumor


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative

Cannot be assessed from the submitted specimen


Question: How should regional nodal tumor burden be categorized?

Choices:
A. Cannot be assessed from the submitted specimen
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. At least one macrometastasis


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis

Cannot be assessed from the submitted specimen


Question: Which nodal tumor-burden category should be entered for this case?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative

Cannot be assessed from the submitted specimen


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Close but negative
D. Positive for invasive tumor


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Positive for invasive tumor
D. Close but negative


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. At least one macrometastasis
B. Cannot be assessed from the submitted specimen
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What is the greatest anatomic extent of invasion by this renal tumor?

Choices:
A. Confined to the kidney
B. Invades a major renal vein branch or the vena cava
C. Invades perinephric or renal sinus soft tissue
D. Extends beyond Gerota fascia or directly invades an adjacent organ

Invades perinephric or renal sinus soft tissue


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Negative with a clear margin


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. Isolated tumor cells or micrometastasis only
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. No metastatic tumor identified


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Negative with a clear margin
D. Positive for invasive tumor

Cannot be assessed from the submitted specimen


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: Which nodal involvement category is supported by the examined sections?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Negative with a clear margin


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: Which level of local invasion is supported by the submitted sections of this renal tumor?

Choices:
A. Extends beyond Gerota fascia or directly invades an adjacent organ
B. Invades perinephric or renal sinus soft tissue
C. Invades a major renal vein branch or the vena cava
D. Confined to the kidney

Invades perinephric or renal sinus soft tissue


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. Isolated tumor cells or micrometastasis only
B. Cannot be assessed from the submitted specimen
C. No metastatic tumor identified
D. At least one macrometastasis

Cannot be assessed from the submitted specimen


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Positive for invasive tumor
D. Close but negative


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Negative with a clear margin


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Negative with a clear margin
D. Positive for invasive tumor


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Positive for invasive tumor
D. Close but negative

Cannot be assessed from the submitted specimen


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. Isolated tumor cells or micrometastasis only
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. No metastatic tumor identified

Cannot be assessed from the submitted specimen


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Positive for invasive tumor
D. Close but negative


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. Isolated tumor cells or micrometastasis only
D. No metastatic tumor identified


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Negative with a clear margin
D. Close but negative


Question: What level of nodal metastatic burden is supported by the submitted H&E material?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. Isolated tumor cells or micrometastasis only
B. No metastatic tumor identified
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Close but negative
D. Positive for invasive tumor

Cannot be assessed from the submitted specimen


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Positive for invasive tumor


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Positive for invasive tumor


Question: Which overall regional nodal tumor-burden category is supported by the submitted material?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified

Cannot be assessed from the submitted specimen


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: What deepest anatomic extent should be documented for this urinary bladder tumor?

Choices:
A. Directly invades an adjacent organ or the pelvic or abdominal wall
B. Limited to lamina propria or more superficial tissue
C. Invades muscularis propria
D. Invades perivesical soft tissue


Question: How should local extension of this colorectal tumor be categorized morphologically?

Choices:
A. Extends through muscularis propria into pericolorectal tissue
B. Reaches the serosal surface or directly invades an adjacent organ
C. Limited to the submucosa
D. Invades the muscularis propria


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: How should regional nodal tumor burden be categorized?

Choices:
A. Cannot be assessed from the submitted specimen
B. Isolated tumor cells or micrometastasis only
C. No metastatic tumor identified
D. At least one macrometastasis


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: What is the greatest nodal tumor burden, if any, identified in the submitted material?

Choices:
A. No metastatic tumor identified
B. At least one macrometastasis
C. Isolated tumor cells or micrometastasis only
D. Cannot be assessed from the submitted specimen


Question: Which overall regional nodal tumor-burden category is supported by the submitted material?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. No metastatic tumor identified
D. Cannot be assessed from the submitted specimen


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: What level of nodal metastatic burden is supported by the submitted H&E material?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. Isolated tumor cells or micrometastasis only
D. No metastatic tumor identified

Cannot be assessed from the submitted specimen


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. Cannot be assessed from the submitted specimen
B. Isolated tumor cells or micrometastasis only
C. At least one macrometastasis
D. No metastatic tumor identified


Question: Which level of local invasion is supported by the submitted sections of this renal tumor?

Choices:
A. Invades perinephric or renal sinus soft tissue
B. Extends beyond Gerota fascia or directly invades an adjacent organ
C. Confined to the kidney
D. Invades a major renal vein branch or the vena cava

Invades perinephric or renal sinus soft tissue


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis


Question: What is the greatest nodal tumor burden, if any, identified in the submitted material?

Choices:
A. No metastatic tumor identified
B. Cannot be assessed from the submitted specimen
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Positive for invasive tumor


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. Isolated tumor cells or micrometastasis only
D. No metastatic tumor identified


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. Cannot be assessed from the submitted specimen
B. At least one macrometastasis
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: How should the invasive-tumor margin assessment appear in the final report?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Negative with a clear margin


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative

Cannot be assessed from the submitted specimen


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Positive for invasive tumor
D. Negative with a clear margin


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Negative with a clear margin
B. Close but negative
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Negative with a clear margin
D. Close but negative


Question: What is the largest metastatic deposit category, if any, supported by the submitted material?

Choices:
A. Cannot be assessed from the submitted specimen
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Negative with a clear margin


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Negative with a clear margin
D. Positive for invasive tumor


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Positive for invasive tumor
D. Close but negative


Question: What is the deepest local extension of this urinary bladder tumor?

Choices:
A. Directly invades an adjacent organ or the pelvic or abdominal wall
B. Invades perivesical soft tissue
C. Limited to lamina propria or more superficial tissue
D. Invades muscularis propria


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Negative with a clear margin


Question: What final local-invasion category should be assigned to this colorectal tumor?

Choices:
A. Extends through muscularis propria into pericolorectal tissue
B. Limited to the submucosa
C. Invades the muscularis propria
D. Reaches the serosal surface or directly invades an adjacent organ

Extends through muscularis propria into pericolorectal tissue


Question: What is the greatest nodal tumor burden, if any, identified in the submitted material?

Choices:
A. Cannot be assessed from the submitted specimen
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. At least one macrometastasis


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. Cannot be assessed from the submitted specimen
B. Isolated tumor cells or micrometastasis only
C. At least one macrometastasis
D. No metastatic tumor identified

Isolated tumor cells or micrometastasis only


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor

Cannot be assessed from the submitted specimen


Question: Which nodal involvement category is supported by the examined sections?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. Cannot be assessed from the submitted specimen


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin

Cannot be assessed from the submitted specimen


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: How should the maximum regional nodal tumor-burden category be documented?

Choices:
A. Cannot be assessed from the submitted specimen
B. No metastatic tumor identified
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only

Cannot be assessed from the submitted specimen


Question: What final margin category should be entered for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Close but negative
C. Cannot be assessed from the submitted specimen
D. Negative with a clear margin


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis

Cannot be assessed from the submitted specimen


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Positive for invasive tumor


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. At least one macrometastasis


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Cannot be assessed from the submitted specimen
D. Isolated tumor cells or micrometastasis only


Question: Which description best matches the greatest anatomic extent of invasion by this renal tumor?

Choices:
A. Invades perinephric or renal sinus soft tissue
B. Confined to the kidney
C. Extends beyond Gerota fascia or directly invades an adjacent organ
D. Invades a major renal vein branch or the vena cava

Invades perinephric or renal sinus soft tissue


Question: How should the closest relevant margin be reported in relation to invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Positive for invasive tumor
D. Close but negative


Question: What final local-invasion category should be assigned to this renal tumor?

Choices:
A. Extends beyond Gerota fascia or directly invades an adjacent organ
B. Confined to the kidney
C. Invades a major renal vein branch or the vena cava
D. Invades perinephric or renal sinus soft tissue


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: How should regional nodal tumor burden be categorized?

Choices:
A. At least one macrometastasis
B. Cannot be assessed from the submitted specimen
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only

Cannot be assessed from the submitted specimen


Question: Which nodal involvement category is supported by the examined sections?

Choices:
A. No metastatic tumor identified
B. Isolated tumor cells or micrometastasis only
C. At least one macrometastasis
D. Cannot be assessed from the submitted specimen


Question: Which overall regional nodal tumor-burden category is supported by the submitted material?

Choices:
A. Cannot be assessed from the submitted specimen
B. Isolated tumor cells or micrometastasis only
C. At least one macrometastasis
D. No metastatic tumor identified


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Close but negative
D. Positive for invasive tumor

Cannot be assessed from the submitted specimen


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Close but negative
D. Cannot be assessed from the submitted specimen

Cannot be assessed from the submitted specimen


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Close but negative
D. Negative with a clear margin


Question: Which description best reflects the status of the submitted resection margins for invasive tumor?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Cannot be assessed from the submitted specimen
D. Positive for invasive tumor


Question: What is the greatest nodal tumor burden, if any, identified in the submitted material?

Choices:
A. At least one macrometastasis
B. Cannot be assessed from the submitted specimen
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Positive for invasive tumor
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Close but negative


Question: Which finding best summarizes involvement of the regional lymph nodes?

Choices:
A. Cannot be assessed from the submitted specimen
B. No metastatic tumor identified
C. At least one macrometastasis
D. Isolated tumor cells or micrometastasis only


Question: What final margin status should be assigned for invasive tumor?

Choices:
A. Negative with a clear margin
B. Positive for invasive tumor
C. Cannot be assessed from the submitted specimen
D. Close but negative


Question: Based on the submitted material, what is the greatest regional nodal tumor burden that can be assessed?

Choices:
A. Isolated tumor cells or micrometastasis only
B. At least one macrometastasis
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Close but negative
C. Negative with a clear margin
D. Positive for invasive tumor

Cannot be assessed from the submitted specimen


Question: How should regional nodal tumor burden be categorized?

Choices:
A. At least one macrometastasis
B. Isolated tumor cells or micrometastasis only
C. Cannot be assessed from the submitted specimen
D. No metastatic tumor identified


Question: What is the most adverse invasive-tumor margin status in the submitted specimen?

Choices:
A. Cannot be assessed from the submitted specimen
B. Negative with a clear margin
C. Close but negative
D. Positive for invasive tumor


Question: Which category best summarizes tumor involvement of the regional lymph nodes?

Choices:
A. At least one macrometastasis
B. No metastatic tumor identified
C. Isolated tumor cells or micrometastasis only
D. Cannot be assessed from the submitted specimen


Question: What final nodal tumor-burden category should be assigned?

Choices:
A. At least one macrometastasis
B. Cannot be assessed from the submitted specimen
C. No metastatic tumor identified
D. Isolated tumor cells or micrometastasis only


Question: How should invasive-tumor margin status be recorded?

Choices:
A. Close but negative
B. Positive for invasive tumor
C. Negative with a clear margin
D. Cannot be assessed from the submitted specimen


Question: What is the status of the submitted margins with respect to invasive tumor?

Choices:
A. Positive for invasive tumor
B. Negative with a clear margin
C. Close but negative
D. Cannot be assessed from the submitted specimen


Question: Which anatomic level of invasion is reached by this renal tumor?

Choices:
A. Extends beyond Gerota fascia or directly invades an adjacent organ
B. Invades a major renal vein branch or the vena cava
C. Confined to the kidney
D. Invades perinephric or renal sinus soft tissue

Invades perinephric or renal sinus soft tissue


Question: What should be communicated about the closest relevant margin for invasive tumor?

Choices:
A. Cannot be assessed from the submitted specimen
B. Positive for invasive tumor
C. Negative with a clear margin
D. Close but negative

Cannot be assessed from the submitted specimen


Question: Considering all relevant margins, which margin-status category is most adverse for invasive tumor?

Choices:
A. Negative with a clear margin
B. Cannot be assessed from the submitted specimen
C. Positive for invasive tumor
D. Close but negative


Question: What margin assessment is supported for invasive tumor in this specimen?

Choices:
A. Close but negative
B. Negative with a clear margin
C. Positive for invasive tumor
D. Cannot be assessed from the submitted specimen


Question: What margin status is supported for invasive tumor in the submitted specimen?

Choices:
A. Close but negative
B. Cannot be assessed from the submitted specimen
C. Negative with a clear margin
D. Positive for invasive tumor